| Biological Information | |
|---|---|
| Background Information: | STK32A (Serine/Threonine Kinase 32A) is a serine/threonine protein kinase that is expressed in a variety of tissues, including the brain, liver, and heart. STK32A has been implicated in the regulation of several cellular processes, including cell proliferation, cell survival, and autophagy.
Research has suggested that STK32A may play a role in the development and progression of cancer. STK32A has been shown to be overexpressed in several types of cancer, including lung cancer, breast cancer, and ovarian cancer, and high levels of STK32A expression have been associated with poor prognosis. Additionally, STK32A has been suggested as a potential therapeutic target in cancer, and efforts to develop small-molecule inhibitors of the kinase are underway. |
| Target Class: | Kinase |
| Accession Number: | NM_001112724.1 |
| Target Name: | STK32A |
| Target Species: | Human |
| Usage | |
| Product Type: | Enzymes |
| Application: | Drug Discovery & Development |
| Storage Conditions: | 1 year at -70°C |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
STK32A, active
N-terminal 6His-tagged recombinant, human STK32A full length.
Datasheets
16-011x Datasheet
View Document